Bioproduction des immunothérapies en France

27-09-2017

Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generation of RNA delivery particle and its applications in gene editing and immunotherapy.